Insight into highly conserved h1 subtype-specific epitopes in influenza virus hemagglutinin

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Cho, Ki Joon ^a   Hong, Kwang W ^b   Kim, Se Ho ^c   Seok, Jong Hyeon ^a   Kim, Sella ^a   Lee, Ji Hye ^a   Saelens, Xavier ^d,e   Kim, Kyung Hyun ^a  

^a Korea University   (South Korea)

^b Green Cross Company   (South Korea)

^c Kangwon National University   (South Korea)

^d DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^e GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMINE; IMMUNOGLOBULIN F(AB) FRAGMENT; INFLUENZA VIRUS HEMAGGLUTININ; LYSINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY GC0346; MONOCLONAL ANTIBODY GC0352; MONOCLONAL ANTIBODY GC0587; MONOCLONAL ANTIBODY GC0757; MONOCLONAL ANTIBODY GC1245; MONOCLONAL ANTIBODY GC1289; MONOCLONAL ANTIBODY GC1517; MONOCLONAL ANTIBODY GC1747; MONOCLONAL ANTIBODY GC1761; SERINE; UNCLASSIFIED DRUG; EPITOPE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGENICITY; ARTICLE; BETA SHEET; BINDING AFFINITY; COMPLEX FORMATION; CONTROLLED STUDY; DRUG PROTEIN BINDING; DRUG STRUCTURE; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA A VIRUS (A/CALIFORNIA/07/2209(CA07)); INFLUENZA A VIRUS (A/KOREA/01/2209(KR01)); INFLUENZA A VIRUS A/ANHUI/1/2005(H5N1); INFLUENZA A VIRUS A/BAR HEADED GOOSE/QINGHAI/14/2008(H5N1); INFLUENZA A VIRUS A/BREVIG MISSION/1/1918(H1N1); INFLUENZA A VIRUS A/BRISBANE/10/2007(H3N2); INFLUENZA A VIRUS A/BRISBANE/59/2007(H1N1); INFLUENZA A VIRUS A/CALIFORNIA/04/2009(H1N1); INFLUENZA A VIRUS A/INDONESIA/5/2005(H5N1); INFLUENZA A VIRUS A/JAPAN/305/1957(H2N2); INFLUENZA A VIRUS A/NETHERLANDS/219/03(H7N7); INFLUENZA A VIRUS A/TURKEY/1/2005(H5N1); INFLUENZA A VIRUS A/VIET NAM/1194/2004(H5N1); INFLUENZA A VIRUS A/VIET NAM/1203/2004(H5N1); INFLUENZA VIRUS A; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PROTEIN STRUCTURE; VIRUS NEUTRALIZATION; VIRUS STRAIN; CHEMICAL STRUCTURE; CRYSTALLIZATION; GENETICS; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROTEIN CONFORMATION; SEQUENCE ALIGNMENT; SERODIAGNOSIS;

ANTIBODIES, MONOCLONAL; BASE SEQUENCE; CONSERVED SEQUENCE; CRYSTALLIZATION; EPITOPES; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; PROTEIN CONFORMATION; SEQUENCE ALIGNMENT;

EID: 84896382466     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089803     Document Type: Article

References (41)

1. Kwong JC, Stukel TA, Lim J, McGeer AJ, Upshur RE, et al. (2008) The effect of universal influenza immunization on mortality and health care use. PLoS Med 5: e211.
2. Dushoff J, Plotkin JB, Viboud C, Earn DJ, Simonsen L (2006) Mortality due to influenza in the United States-an annualized regression approach using multiple-cause mortality data. Am J Epidemiol 163: 181-187. (Pubitemid 43068987)
3. Johnson NP, Mueller J (2002) Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic. Bull Hist Med 76: 105-115.
4. WHO.
5. Cox NJ, Subbarao K (2000) Global epidemiology of influenza: past and present. Annu Rev Med 51: 407-421. (Pubitemid 30216046)
6. Osterhaus AD, Rimmelzwaan GF, Martina BE, Bestebroer TM, Fouchier RA (2000) Influenza B virus in seals. Science 288: 1051-1053. (Pubitemid 30324237)
7. Gamblin SJ, Skehel JJ (2010) Influenza hemagglutinin and neuraminidase membrane glycoproteins. J Biol Chem 285: 28403-28409.
8. Pielak RM, Chou JJ (2011) Influenza M2 proton channels. Biochim Biophys Acta 1808: 522-529.
9. Rohm C, Zhou N, Suss J, Mackenzie J, Webster RG (1996) Characterization of a novel influenza hemagglutinin, H15: criteria for determination of influenza A subtypes. Virology 217: 508-516. (Pubitemid 26121177)
10. Zhu X, Yu W, McBride R, Li Y, Chen LM, et al. (2013) Hemagglutinin homologue from H17N10 bat influenza virus exhibits divergent receptor-binding and pH-dependent fusion activities. Proc Natl Acad Sci U S A 110: 1458-1463.
11. Taubenberger JK, Reid AH, Lourens RM, Wang R, Jin G, et al. (2005) Characterization of the 1918 influenza virus polymerase genes. Nature 437: 889-893. (Pubitemid 41486764)
12. Neumann G, Kawaoka Y (2006) Host range restriction and pathogenicity in the context of influenza pandemic. Emerg Infect Dis 12: 881-886. (Pubitemid 43848407)
13. Zimmer SM, Burke DS (2009) Historical perspective-Emergence of influenza A (H1N1) viruses. N Engl J Med 361: 279-285.
14. Xu R, Ekiert DC, Krause JC, Hai R, Crowe JE Jr, et al. (2010) Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 328: 357-360.
15. Gething MJ, Doms RW, York D, White J (1986) Studies on the mechanism of membrane fusion: site-specific mutagenesis of the hemagglutinin of influenza virus. J Cell Biol 102: 11-23. (Pubitemid 16155549)
16. Copeland CS, Zimmer KP, Wagner KR, Healey GA, Mellman I, et al. (1988) Folding, trimerization, and transport are sequential events in the biogenesis of influenza virus hemagglutinin. Cell 53: 197-209.
17. Hebert DN, Foellmer B, Helenius A (1995) Glucose trimming and reglucosylation determine glycoprotein association with calnexin in the endoplasmic reticulum. Cell 81: 425-433.
18. Steinhauer DA (1999) Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology 258: 1-20.
19. Klenk HD, Rott R, Orlich M, Blodorn J (1975) Activation of influenza A viruses by trypsin treatment. Virology 68: 426-439.
20. Okuno Y, Isegawa Y, Sasao F, Ueda S (1993) A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J Virol 67: 2552-2558. (Pubitemid 23118850)
21. Ekiert DC, Friesen RH, Bhabha G, Kwaks T, Jongeneelen M, et al. (2011) A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 333: 843-850.
22. Corti D, Voss J, Gamblin SJ, Codoni G, Macagno A, et al. (2011) A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333: 850-856.
23. Whittle JR, Zhang R, Khurana S, King LR, Manischewitz J, et al. (2011) Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin. Proc Natl Acad Sci U S A 108: 14216-14221.
24. Sui J, Hwang WC, Perez S, Wei G, Aird D, et al. (2009) Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol 16: 265-273.
25. Mueller M, Renzullo S, Brooks R, Ruggli N, Hofmann MA (2010) Antigenic characterization of recombinant hemagglutinin proteins derived from different avian influenza virus subtypes. PLoS One 5: e9097.
26. Kaverin NV, Rudneva IA, Govorkova EA, Timofeeva TA, Shilov AA, et al. (2007) Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies. J Virol 81: 12911-12917. (Pubitemid 350156928)
27. Vareckova E, Cox N, Klimov A (2002) Evaluation of the subtype specificity of monoclonal antibodies raised against H1 and H3 subtypes of human influenza A virus hemagglutinins. J Clin Microbiol 40: 2220-2223. (Pubitemid 34596411)
28. Cho KJ, Lee JH, Hong KW, Kim SH, Park Y, et al. (2013) Insight into structural diversity of influenza virus hemagglutinin. J Gen Virol. 94: 1712-1722.
29. Skehel JJ, Wiley DC (2000) Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69: 531-569.
30. Harrison SC (2008) Viral membrane fusion. Nat Struct Mol Biol 15: 690-698.
31. Volpe JM, Kepler TB (2008) Large-scale analysis of human heavy chain V(D)J recombination patterns. Immunome Res 4: 3.
32. Salzberg S (2008) The contents of the syringe. Nature 454: 160-161.
33. Zhao R, Cui S, Guo L,Wu C, Gonzalez R, et al. (2011) Identification of a highly conserved H1 subtype-specific epitope with diagnostic potential in the hemagglutinin protein of influenza A virus. PLoS One 6: e23374.
34. Bhardwaj A, Walker-Kopp N, Wilkens S, Cingolani G (2008) Foldon-guided self-assembly of ultra-stable protein fibers. Protein Sci 17: 1475-1485.
35. Otwinowski Z, Minor W (1997) Processing of X-ray diffraction data collected in oscillation mode. Macromolecular Crystallography, Pt A 276: 307-326. (Pubitemid 27085611)
36. (1994) The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr 50: 760-763.
37. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, et al. (2010) PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66: 213-221.
38. Emsley P, Cowtan K (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60: 2126-2132. (Pubitemid 41742764)
39. Brunger AT (1992) Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature 355: 472-475.
40. Laskowski RA, Moss DS, Thornton JM (1993) Main-chain bond lengths and bond angles in protein structures. J Mol Biol 231: 1049-1067. (Pubitemid 23209879)
41. Laskowski RA, MacArthus MW, Moss DS, Thornton JM (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Cryst 26: 283-291.